Articles scientifiques

Breast cancer control in China: challenges and opportunities of the use of population-based routine data studies.

Auteurs : Pinto AC, Canário R, Fidalgo P
Année : 2014
Journal : J Thorac Dis
Volume : 6(9)
Pages : 1167-9

Prominent role of cyclic adenosine monophosphate signalling pathway in the sensitivity of (WT)BRAF/(WT)NRAS melanoma cells to vemurafenib.

Auteurs : Krayem M, Journe F, Wiedig M, Morandini R, Sales F, Awada A, Ghanem G
Année : 2014
Journal : Eur. J. Cancer
Volume : 50(7)
Pages : 1310-20

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2).

Auteurs : Cardoso F, Costa A, Norton L, Senkus E, Aapro M, André F, Barrios CH, Bergh J, Biganzoli L, Blackwell KL, Cardoso MJ, Cufer T, El Saghir N, Fallowfield L, Fenech D, Francis P, Gelmon K, Giordano SH, Gligorov J, Goldhirsch A, Harbeck N, Houssami N, Hudis C, Kaufman B, Krop I, Kyriakides S, Lin UN, Mayer M, Merjaver SD, Nordström EB, Pagani O, Partridge A, Penault-Llorca F, Piccart-Gebhart M, Rugo H, Sledge G, Thomssen C, + collaborators (among others :, Winer A
Année : 2014
Journal : Breast
Volume : 23(5)
Pages : 489-502

What is your diagnosis ?

Auteurs : de Azambuja E
Année : 2014
Journal : Belgian J Medical Oncology
Volume : 8(1)
Pages : 21-22

The landscape of medical oncology in Europe by 2020.

Auteurs : de Azambuja E, Ameye L, Paesmans M, Zielinski CC, Piccart-Gebhart M, Preusser M
Année : 2014
Journal : Ann Oncol
Volume : 25(2)
Pages : 525-8

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†.

Auteurs : Cardoso F, Costa A, Norton L, Senkus E, Aapro M, André F, Barrios CH, Bergh J, Biganzoli L, Blackwell KL, Cardoso MJ, Cufer T, El Saghir N, Fallowfield L, Fenech D, Francis P, Gelmon K, Giordano SH, Gligorov J, Goldhirsch A, Harbeck N, Houssami N, Hudis C, Kaufman B, Krop I, Kyriakides S, Lin UN, Mayer M, Merjaver SD, Nordström EB, Pagani O, Partridge A, Penault-Llorca F, Piccart-Gebhart M, Rugo H, Sledge G, Thomssen C
Année : 2014
Journal : Ann Oncol
Volume : 25(10)
Pages : 1871-88

Circulating tumor cells and circulating tumor DNA for precision medicine: dream or reality?

Auteurs : Ignatiadis M, Dawson SJ
Année : 2014
Journal : Ann Oncol
Volume : 25(12)
Pages : 2304-2313

Molecular biology in medical oncology: diagnosis, prognosis, and precision medicine.

Auteurs : Aftimos P, Barthelemy P, Awada A
Année : 2014
Journal : Discov Med
Volume : 17(92)
Pages : 81-91

Words matter: distinguishing personalized medicine" and "biologically personalized therapeutics"."

Auteurs : Cherny NI, de Vries EG, Emanuel L, Fallowfield L, Francis PA, Gabizon A, Piccart-Gebhart M, Sidransky D, Soussan-Gutman L, Tziraki C
Année : 2014
Journal : J. Natl. Cancer Inst.
Volume : 106(12)

Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data.

Auteurs : Bidard FC, Peeters DJ, Fehm T, Nolé F, Gisbert-Criado R, Mavroudis D, Grisanti S, Generali D, Garcia-Saenz JA, Stebbing J, Caldas C, Gazzaniga P, Manso L, Zamarchi R, de Lascoiti AF, De Mattos-Arruda L, Ignatiadis M, Lebofsky R, Van Laere SJ, Meier-Stiegen F, Sandri MT, Vidal-Martinez J, Politaki E, Consoli F, Bottini A, Diaz-Rubio E, Krell J, Dawson SJ, Raimondi C, Rutten A, Janni W, Munzone E, Carañana V, Agelaki S, Almici C, Dirix L, Solomayer EF, Zorzino L, Johannes H, Reis-Filho JS, Pantel K, Pierga JY, Michiels S
Année : 2014
Journal : Lancet Oncol
Volume : 15(4)
Pages : 406-14

The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO).

Auteurs : Popescu RA, Schäfer R, Califano R, Eckert R, Coleman R, Douillard JY, Cervantes A, Casali PG, Sessa C, van Cutsem E, De Vries E, Pavlidis N, Fumasoli K, Wörmann B, Samonigg H, Cascinu S, Cruz Hernández JJ, Howard AJ, Ciardiello F, Stahel RA, Piccart-Gebhart M
Année : 2014
Journal : Ann Oncol
Volume : 25(1)
Pages : 9-15

Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2.

Auteurs : Rugo HS, Pritchard KI, Gnant M, Noguchi S, Piccart-Gebhart M, Hortobagyi G, Baselga J, Perez A, Geberth M, Csoszi T, Chouinard E, Srimuninnimit V, Puttawibul P, Eakle J, Feng W, Bauly H, El-Hashimy M, Taran T, Burris HA
Année : 2014
Journal : Ann Oncol
Volume : 25(4)
Pages : 808-15

Luminal B Breast Cancer: Molecular Characterization, Clinical Management, and Future Perspectives.

Auteurs : Ades F, Zardavas D, Bozovic-Spasojevic I, Pugliano L, Fumagalli D, de Azambuja E, Viale G, Sotiriou C, Piccart-Gebhart M
Année : 2014
Journal : J. Clin. Oncol.
Volume : 32(25)
Pages : 2794-803

Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial.

Auteurs : Bonnefoi H, Litière S, Piccart-Gebhart M, Macgrogan G, Fumoleau P, Brain E, Petit T, Rouanet P, Jassem J, Moldovan C, Bodmer A, Zaman K, Cufer T, Campone M, Luporsi E, Malmström P, Werutsky G, Bogaerts J, Bergh J, Cameron DA
Année : 2014
Journal : Ann Oncol
Volume : 25(6)
Pages : 1128-36

A phase I pharmacokinetics study of lapatinib and tamoxifen in metastatic breast cancer (EORTC 10053 Lapatam study).

Auteurs : Fumoleau P, Koch KM, Brain E, Lokiec F, Rezai K, Awada A, Hayward L, Werutsky G, Bogaerts J, Marréaud S, Cardoso F
Année : 2014
Journal : Breast
Volume : 23(5)
Pages : 663-9

A rare case of prostatic extra gonadal germ cell tumor in a young adult: Review of the literature

Auteurs : Sideris S, Aftimos P, Georgala A, Sirtaine N, Awada A, Gil T
Année : 2014
Journal : J Clin Diagn Res
Volume : 2
Pages : 2

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis.

Auteurs : Cortazar P, Zhang L, Untch M, Mehta K, Costantino JP, Wolmark N, Bonnefoi H, Cameron D, Gianni L, Valagussa P, Swain SM, Prowell T, Loibl S, Wickerham DL, Bogaerts J, Baselga J, Perou C, Blumenthal G, Blohmer J, Mamounas EP, Bergh J, Semiglazov V, Justice R, Eidtmann H, Paik S, Piccart-Gebhart M, Sridhara R, Fasching PA, Slaets L, Tang S, Gerber B, Geyer CE, Pazdur R, Ditsch N, Rastogi P, Eiermann W, Von Minckwitz G
Année : 2014
Journal : Lancet
Volume : 384(9938)
Pages : 164-72

The Role of Age on Dose Limiting Toxicities (DLTs) in Phase I Dose-escalation Trials.

Auteurs : Schwandt A, Harris PJ, Hunsberger S, Deleporte A, Smith GL, Vulih D, Anderson BD, Ivy SP
Année : 2014
Journal : Clin Cancer Res
Volume : 20(18)
Pages : 4768-75

Prospective non-interventional multicentre observational trial of first-line anti-cancer treatment in patients with metastatic renal cell cancer in Belgium.

Auteurs : Cornelis N, Vermassen T, Schallier D, Machiels JP, Gil T, Debruyne PR, DHondt R, Bols A, Schrijvers D, Mebis J, Lumen N, Rottey S
Année : 2014
Journal : Acta Clin Belg
Volume : 69(5)
Pages : 335-40

Delivering precision medicine in oncology today and in future-the promise and challenges of personalised cancer medicine: a position paper by the European Society for Medical Oncology (ESMO).

Auteurs : Ciardiello F, Arnold D, Casali PG, Cervantes A, Douillard JY, Eggermont A, Eniu A, McGregor K, Peters S, Piccart-Gebhart M, Popescu R, van Cutsem E, Zielinski C, Stahel R
Année : 2014
Journal : Ann Oncol
Volume : 25(9)
Pages : 1673-8